Investigational Site Number — Birmingham, Alabama

Investigational Site Number is a clinical research site located in Birmingham, Alabama, United States 35205.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number has participated in 1 clinical trials.

Therapeutic areas: Mixed Gliomas, Malignant Gliomas, Glioblastoma Multiforme.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number?

Investigational Site Number has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number conducted?

Investigational Site Number has 1 clinical trials on record. Their work covers Mixed Gliomas, Malignant Gliomas, Glioblastoma Multiforme.

Is Investigational Site Number accredited by Crixeo Health?

Investigational Site Number has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.